Funder
Ministry of Science and Technology, Taiwan
National Health Research Institutes, Taiwan
Academia Sinica, Taiwan
Program for Translational Innovation of Biopharmaceutical Development - Technology Supporting Platform Axis (Grant No. AS-KPQ-106-TSPA), Academia Sinica, Taiwan
Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan
KMU-KMUH Co-Project of Key Research
Kaohsiung Medical University, Taiwan
Reference38 articles.
1. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management;Stein;Ther. Adv. Med. Oncol.,2010
2. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis;Swami;Curr. Drug Targets,2013
3. Intestinal microflora and digestive toxicity of irinotecan in mice;Brandi;Clin. Cancer Res.,2006
4. Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase;Rivory;Biochem. Pharmacol.,1996
5. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D;Jinno;Drug Metab. Dispos.,2003
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献